-
My Account
In App
My Account
BSE Live
Jan 16, 10:07Prev. Close
6356.75
Open Price
6317.20
Bid Price (Qty.)
6336.05 (13)
Offer Price (Qty.)
6343.95 (10)
NSE Live
Jan 16, 10:07Prev. Close
6355.50
Open Price
6355.50
Bid Price (Qty.)
6340.00 (1)
Offer Price (Qty.)
6341.00 (31)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 1,067.18 | 1,008.64 | 791.58 | 694.86 | 479.05 | |
| Net CashFlow From Operating Activities | 822.44 | 558.15 | 467.54 | 334.05 | 325.96 | |
| Net Cash Used In Investing Activities | -520.77 | -305.08 | -239.24 | -204.35 | -221.99 | |
| Net Cash Used From Financing Activities | -302.95 | -248.50 | -230.73 | -131.11 | -104.16 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -1.28 | 4.57 | -2.43 | -1.40 | -0.19 | |
| Cash And Cash Equivalents Begin of Year | 10.35 | 5.78 | 8.20 | 9.60 | 9.80 | |
| Cash And Cash Equivalents End Of Year | 9.06 | 10.35 | 5.78 | 8.20 | 9.60 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill
